ALLMAX NUTRITION

Rapidcuts Shredded

Serving

1 Capsule(s)

Per container

Form

capsule-unknown

DSLD

211148

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 4 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

19 active ingredients

Ingredient	Amount	% DV
Niacin UNII · 2679MF687A	12 mg	60%
Selenium UNII · H6241UJ22B	43 mcg	61%
Chromium UNII · 0R0008Q3JB	60 mcg	50%
Ashwagandha (Withania somnifera, root & leaf) extract Ashwagandha	63 mg	—
Korean Ginseng (Panax ginseng) root extract Oriental Ginseng	12 mg	—
Olive (Olea europaea, leaf) powder Olive	30 mg	—
Kelp (Fucus vesiculosus, whole) powder Kelp	5 mg	—
Cinnulin PF (Cinnamomum burmannii, bark) extract Cinnamomum burmanii	10 mg	—
N-Methyl-Tyramine HCl N-Methyltyramine	3.6 mg	—
Naturate Yerba Mate (Ilex paraguariensis, leaf) extract Mate	25 mg	—
Green Tea (Camilia sinensis, leaf) extract Green Tea	25 mg	—
Hordenine HCl Hordenine	16 mg	—
Yohimbe (Pausinystalia yohimbe) bark extract Yohimbe	4.5 mg	—
Caffeine Anhydrous CaffeineUNII · 3G6A5W338E	190 mg	—
Di-Caffeine Malate Caffeine	27 mg	—
Naringin extract Naringenin	19 mg	—
Guarana (Paullinia cupana) seed extract Guarana	17 mg	—
Capsimax Capsicum (Capsicum annuum, fruit) extract Capsicum	13 mg	—
Bioperine Black Pepper (Piper nigrum) fruit extract Black Pepper	2.5 mg	—

Flagged excipients

5 flagged · authority citations

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Yellow #5
color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
eur-lex.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Yellow #6
color
EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.
eur-lex.europa.eu →
◐ CAUTIONFD&C Red #40
color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
eur-lex.europa.eu →leginfo.legislature.ca.gov →
◐ CAUTIONFD&C Blue #1
color
EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.
eur-lex.europa.eu →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Magnesium Stearate · Silica